Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hampel

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer riskT S Frank, S A Manley, O I Olopade, et al.
Molecular Psychiatry|July 30, 2008
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter studyP Lewczuk, H Kamrowski-Kruck, O Peters, et al.
American Journal of Human Genetics|September 6, 2001
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromesX P Zhou, K Woodford-Richens, R Lehtonen, et al.
Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.
The Journal of Prevention of Alzheimer'S Disease|October 20, 2015
The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target PopulationsE Cavedo, S Lista, Z Khachaturian, et al.
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
Neurobiology of Aging|June 20, 2000
Inflammation and Alzheimer's diseaseH Akiyama, S Barger, S Barnum, et al.
Molecular Psychiatry|March 18, 2015
A novel Alzheimer disease locus located near the gene encoding tau proteinG Jun, C A Ibrahim-Verbaas, M Vronskaya, et al.
Nature Genetics|October 29, 2013
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseJ C Lambert, C A Ibrahim-Verbaas, D Harold, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer riskT S Frank, S A Manley, O I Olopade, et al.
Molecular Psychiatry|July 30, 2008
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter studyP Lewczuk, H Kamrowski-Kruck, O Peters, et al.
American Journal of Human Genetics|September 6, 2001
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromesX P Zhou, K Woodford-Richens, R Lehtonen, et al.
Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.
The Journal of Prevention of Alzheimer'S Disease|October 20, 2015
The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target PopulationsE Cavedo, S Lista, Z Khachaturian, et al.
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
Neurobiology of Aging|June 20, 2000
Inflammation and Alzheimer's diseaseH Akiyama, S Barger, S Barnum, et al.
Molecular Psychiatry|March 18, 2015
A novel Alzheimer disease locus located near the gene encoding tau proteinG Jun, C A Ibrahim-Verbaas, M Vronskaya, et al.
Nature Genetics|October 29, 2013
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseJ C Lambert, C A Ibrahim-Verbaas, D Harold, et al.
Pageof 19